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Following the demonstration by Tocantins and his coworkers (1, 2) of the
feasibility of introducing blood and other fluids into the body by way of the bone
marrow, it was felt that this route might be applicable to the massive arseno-
therapy of syphilis by the drip method (3). In human beings, Tocantins advises
this route only when veins are not accessible, as in infants and obese adults. If
massive arsenotherapy should be more widely used, and if it should be applied to
children, an increasing number of patients with inaccessible veins would be
encountered. An experiment was therefore planned to determine what effect
mapharsen solution given by this route might have on the bone marrow and
the other viscera.
METHOD
Nine adult male rabbits of various breeds, weighing from 2200 to 5600 gms.
were used. The tibia, femur and humerus were the bones selected for injection.
In preliminary experiments the 15 gauge needle used by Tocantins in human
beings was found to be too large, causing later fractures at the site. Smaller
needles, when used without a stilette, were too fragile and bent when introduction
through bone was attempted. In a few rabbits the bone was exposed and treph-
med with an electric dental burr. This, however, was found unsatisfactory, as
it was difficult to fit the needle exactly into the burr hole, and leakage from the
bone resulted. A sharp 18 gauge needle with fitted stilette, similar to a lumbar
puncture needle, was finally found to be most satisfactory, and was used through-
out the experiment. The needle was inserted through the skin until bone was
reached, and then rotated with moderate pressure until the tip entered the
marrow cavity. Aspiration of blood marrow mixture was only occasionally
successful, due probably to the small calibre of the needle. After injection by
syringe of 2 to 3 cc. of fluid to clear the lumen and to make certain that the tip
was securely in the marrow cavity, the gravity drip apparatus was attached.
This consisted of a 50 cc. graduated glass burette, with a drip bulb, to which was
attached by a Y tube an inverted flask of the solution, in order to refill the
burette during the infusion. In some animals the same bone was utilized for two
or even three daily treatments, but in most cases a different bone was used
each day.
Light anesthesia was maintained during the entire course of each treatment
by repeated intraperitoneal injections of sodium pentobarbital. At the time
of introduction of the needle into the bone, this was reinforced by brief ether
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inhalation. No mechanical restraint was used, the rabbit lying drowsily on its
side during the entire course of the infusion. The total amount of sodium pento-
barbital used in the five days of treatment ranged from 412 to 1600 mgms.
The daily dose of mapharsen2 was 4 mgm. per kilo. body weight, in a dilution
of 1 mgm. mapharsen in 10 cc. of 5% dextrose solution. Seven rabbits were
given five successive daily bone marrow infusions, and were sacrificed from the
5th to the 19th day of the experiment. Two control animals, which received
five daily intravenous infusions, the dosage and dilution of the drug and the ex-
perimental conditions, including anesthesia, being identical to those used in the
test group, were killed on the 10th and 16th days. All animals were sacrificed by
rapid injection of about 5 cc. of air into the marginal ear vein, except for rabbits
48 and 28, which died on the 5th and 7th days respectively. Histologic
study of the bones and viscera was made in each case.3 The mean speed of
injection for each animal for the five days of treatment ranged from 1.3 to 6.3
TABLE 1
Massive arsenotherapy by bone marrow infusion
Five daily treatments of four milligrams mapharsen per kilogram body weight, in a dilution
of one milligram mapharsen to ten cc. of five per cent glucose
TOTAL VOLUME SPEED OF INFUSION, cc/MeN.




Highest Lowest Mean fordays
gms. cc.
48 2405 478 10.9 4.1 6.3 +
46 2410 457 9.3 1.4 5.1
29 4070 813 4.8 0.8 3.3 +
23 4200 807 5.1 1.3 3.0 +
28 5585 1117 4.1 1.1 2.9 +
45 2245 431 5.4 1.4 2.7
44 2510 466 2.7 1.3 2.3 +
cc. per minute, and the total duration of treatment for the five days from 89 to
349 minutes.
RESULTS
Rabbit 48 died suddenly at the end of the fifth treatment in a manner sug-
gesting pulmonary embolism. No air bubbles were seen in the infusion appara-
tus. Rabbit 28 died two days after the end of treatment. The remaining
animals appeared healthy throughout, although most of them lost weight.
The most striking pathological finding was fat embolism in the pulmonary
arterioles, which was seen in 5 of the 7 rabbits treated by the bone marrow route
(see table 1). In one of these ( 48), fat embolism was the cause of sudden death
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Fia. 1. HETVIATOXYLIN-EOSIN STAIN OF LUNG (RABBIT *'48)
Pulmonary arterioles containing large globules. Note foreign body giant cells (X 430>
FIG. 2. Osivuc ACID STAIN OF LUNG (RABBIT *129)
Pulmonary arteriole containing fat globules (X 430)
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at the termination of the fifth treatment. In the others, there was no imme-
diate or delayed clinical evidence of emboli. Hematoxylin-eosin stains showed
unstained large globules, in most cases surrounded by foreign body giant cells,
filling the pulmonary arterioles (fig. 1). That these were fat globules was dem-
onstrated by Scharlach R and osmic acid stains in two of the animals (fig. 2).
In pathologic sections, one control rabbit which received intravenous treatment
showed evidence of multiple pulmonary emboli, which probably were caused by
air through faulty intravenous technic; no fat globules were seen. Lung sections
in the other control rabbit were negative.
Many of the injected bone marrows showed some localized hemorrhage, frag-
mentation of bone, necrosis and polymorphonuclear infiltration, but normal
hematopoesis was seen in each animal. IPetechial hemorrhages were seen occa-
sionally in the lung, spleen, heart, muscle, brain, and in bone marrow not the site
of injection. Acute passive congestion was seen frequently in the liver and
lung, less often in kidney, spleen, heart, and brain. Toxic hepatitis, with focal
necrosis, was observed in one rabbit, bile duct proliferation, probably the healed
stage of a toxic hepatitis in another, and fatty infiltration in several. Cloudy
swelling, desquamation of tubular epithelium, and acute toxic nephritis of vary-
ing degrees were seen in the kidney. The heart showed cellular infiltration,
vacuolar degeneration, and cloudy swelling in several instances. In one rabbit,
perivascular lymphocytic and mononuclear phagocyte infiltration was seen in
the brain. Except for occasional edema, the spleen was not unusual. With
the exception of pulmonary fat embolism and traumatic bone changes, no essen-
tial difference was noted in the histologic studies between rabbits treated by bone
marrow and those treated by intravenous infusion.
DISCUSSION
Tocantins (1) states "there seems to be little ground for fearing fat embolism"
as a result of bone marrow infusions, although he concedes that "some fat is
conceivably displaced into the blood stream". No evidence of fat embolism
was noted in the 40 patients he treated. However, many non-fatal cases are not
recognized because of the lack of a clear-cut clinical picture (4).
It would seem probable that the more rapid the bone marrow infusion and
the higher the pressure of the stream of fluid, the greater would be the likelihood
of rupturing fat cells and forcing fat globules into the venous system. It is of
interest to note that the only fatal fat embolism in this study occurred at the
termination of the most rapid infusion of the entire series, at a rate of 10.9 cc.
per minute. It may be seen in table 1, however, that speed of injection was not
the sole determining factor in the occurrence of fat embolism. Toeantins (1)
reports infusion speeds in human beings of 0.4 to 25 cc. per minute, and in one
case syringe injection at43 cc. per minute. It would appear, on the basis of this
study, that bone marrow infusion may carry fat globules from the bone marrow
into the blood stream, whence they are deposited as emboli in the lung capillaries.
further experimental work should be carried out before bone marrow infusion
can be accepted as a safe procedure in human beings.
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Except for fat embolism, the visceral histologic damage seen in rabbits treated
by bone marrow infusion was essentially the same as that seen in rabbits treated
by vein. The toxicity of mapharsen does not appear to be altered by the
former route. Gruhzit (5) and Magnuson and Raulston (6) found similar
changes in animals following large doses of mapharsen given intravenously.
SUMMARY
Seven rabbits were given massive arsenotherapy by bone marrow infusion
drip, 4 mgm. of mapharsen per kilo. body weight, each day for five successive
days. In two control rabbits, intravenous massive arsenotherapy was ad-
ministered.
Pulmonary fat eniboli were demonstrated in 5 of the 7 rabbits treated via the
bone marrow. No fat emboli were seen in the two animals treated by vein.
CONCLUSION
In view of the finding of pulmonary fat embolism in animals treated by bone
marrow infusion, this procedure cannot at present be considered free from hazard
in human beings.
We wish to thank Dr. Malcolm Soule Professor of Bacteriology of the Univer-
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tality and cooperation.
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